Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab and Diagnostics Limited is an inventive venture in quality healthcare and the pioneer in comprehensive reliance on technological automation.
- Market Cap: 35.59 Cr.
- Current Price: 38.30
- 52 weeks High / Low 38.30 / 36.50
- Book Value: 3.53
- Stock P/E:
- Dividend Yield: 0.00 %
- ROCE: -34.49 %
- ROE: -169 %
- Sales Growth (3Yrs): %
- Listed on BSE
- Company Website
- Face Value: 10.00
Pros:
Company has reduced debt.
Cons:
Stock is trading at 10.85 times its book value
Company has low interest coverage ratio.
Promoter holding has decreased by -5.39% over last quarter
Company has a low return on equity of -122.99% for last 3 years.
Peer comparison Sector: Healthcare // Industry: Healthcare
Loading peers table ...
Quarterly Results Figures in Rs. Crores
| Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.61 | 0.65 | 0.98 | 1.26 | 1.47 | 1.48 | 2.00 | 2.08 | 2.08 | 1.90 | 2.33 | 2.22 | |
| 1.48 | 1.69 | 1.99 | 2.06 | 2.49 | 2.33 | 2.82 | 2.91 | 2.83 | 2.37 | 2.61 | 2.60 | |
| Operating Profit | -0.87 | -1.04 | -1.01 | -0.80 | -1.02 | -0.85 | -0.82 | -0.83 | -0.75 | -0.47 | -0.28 | -0.38 |
| OPM % | -142.62% | -160.00% | -103.06% | -63.49% | -69.39% | -57.43% | -41.00% | -39.90% | -36.06% | -24.74% | -12.02% | -17.12% |
| Other Income | 0.07 | 0.05 | 0.06 | 0.04 | 0.07 | 0.05 | 0.06 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 |
| Interest | 0.08 | 0.14 | 0.20 | 0.18 | 0.29 | 0.28 | 0.26 | 0.16 | 0.26 | 0.25 | 0.24 | 0.28 |
| Depreciation | 0.16 | 0.26 | 0.33 | 0.40 | 0.13 | 0.29 | 0.31 | 0.31 | 0.32 | 0.40 | 0.41 | 0.43 |
| Profit before tax | -1.04 | -1.39 | -1.48 | -1.34 | -1.37 | -1.37 | -1.33 | -1.23 | -1.25 | -1.05 | -0.86 | -1.02 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Net Profit | -1.04 | -1.39 | -1.48 | -1.34 | -1.37 | -1.38 | -1.33 | -1.23 | -1.24 | -1.05 | -0.86 | -1.02 |
| EPS in Rs | -2.07 | -2.67 | -2.85 | -2.59 | -2.64 | -2.65 | -1.62 | -1.50 | -1.52 | -1.28 | -1.05 | -1.10 |
| Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss Figures in Rs. Crores
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.76 | 4.36 | 7.64 | 8.53 | |
| 0.02 | 0.02 | 0.02 | 0.14 | 0.23 | 3.34 | 8.24 | 10.88 | 10.41 | |
| Operating Profit | -0.02 | -0.02 | -0.02 | -0.14 | -0.23 | -2.58 | -3.88 | -3.24 | -1.88 |
| OPM % | -339.47% | -88.99% | -42.41% | -22.04% | |||||
| Other Income | 0.34 | 0.15 | 0.02 | 0.21 | 0.32 | 0.31 | 0.22 | 0.25 | 0.29 |
| Interest | 0.06 | 0.05 | 0.00 | 0.00 | 0.05 | 0.26 | 0.80 | 0.96 | 1.03 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | 1.12 | 1.23 | 1.56 |
| Profit before tax | 0.26 | 0.08 | 0.00 | 0.07 | 0.04 | -2.73 | -5.58 | -5.18 | -4.18 |
| Tax % | 23.08% | 37.50% | 57.14% | 25.00% | -0.00% | -0.00% | -0.00% | ||
| Net Profit | 0.20 | 0.05 | 0.00 | 0.02 | 0.03 | -2.72 | -5.58 | -5.18 | -4.17 |
| EPS in Rs | 5.00 | 1.25 | 0.00 | 0.10 | 0.12 | 0.00 | 0.00 | 0.00 | -4.95 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% | -0.00% | -0.00% |
* Sales is net of excise duty and discounts
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 21.34% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 21.47% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 10.06% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -122.99% |
| Last Year: | -169.00% |
Balance Sheet Figures in Rs. Crores
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Sep 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| 0.40 | 0.40 | 0.40 | 2.25 | 2.25 | 5.19 | 5.19 | 13.73 | 8.19 | |
| Reserves | 0.13 | 0.19 | 0.19 | 1.36 | 1.39 | 0.72 | -4.86 | -7.93 | -4.91 |
| Borrowings | 1.33 | 0.06 | 0.00 | 0.00 | 2.62 | 7.29 | 11.36 | 6.98 | 8.64 |
| 0.20 | 0.01 | 0.03 | 0.21 | 0.03 | 1.66 | 0.84 | 7.56 | 2.33 | |
| Total Liabilities | 2.06 | 0.66 | 0.62 | 3.82 | 6.29 | 14.86 | 12.53 | 14.80 | 14.25 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 7.79 | 7.91 | 8.90 | 8.27 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 |
| Investments | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 1.69 | 0.66 | 0.62 | 3.82 | 6.25 | 6.82 | 4.62 | 5.90 | 5.98 | |
| Total Assets | 2.06 | 0.66 | 0.62 | 3.82 | 6.29 | 14.86 | 12.53 | 14.80 | 14.25 |
Cash Flows Figures in Rs. Crores
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|
| -0.02 | -0.04 | -0.02 | -0.37 | -1.29 | -4.81 | -3.39 | ||
| -1.24 | 1.35 | 0.08 | -0.02 | -10.14 | -0.77 | -1.97 | ||
| 0.61 | -1.33 | -0.06 | 2.64 | 8.91 | 6.52 | 3.35 | ||
| Net Cash Flow | -0.65 | -0.02 | 0.00 | 2.25 | -2.52 | 0.94 | -2.00 |
Ratios Figures in Rs. Crores
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 10.36% | 0.00% | 1.82% | -25.39% | -38.41% | -34.49% | ||
| Debtor Days | 43.22 | 29.30 | 38.22 | |||||
| Inventory Turnover | 0.00 | 12.67 | 17.80 | 23.51 |
Recent announcements
- Non-Applicability Of SEBI Circular No. Sebl/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018 With Regard To Fund Raising By Issuance Of Debt Securities By Large Entities May 14
- Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2020 May 5
- Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2020 May 5
- Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 For The Half Year Ended March 31, 2020 May 1
- Shareholding for the Period Ended March 31, 2020 Apr 24
Annual reports
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse